- Home
- COCH vs MLSS Comparison
COCH vs MLSS Comparison
Compare COCH & MLSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | COCH | MLSS |
|---|---|---|
| Founded | 1995 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.4M | 22.9M |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | COCH | MLSS |
|---|---|---|
| Price | $0.66 | $0.27 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $9.50 | $1.00 |
| AVG Volume (30 Days) | 189.5K | ★ 487.9K |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $208,000.00 | ★ $8,929,517.00 |
| Revenue This Year | N/A | $8.95 |
| Revenue Next Year | $29.53 | $7.51 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 0.59 |
| 52 Week Low | $0.64 | $0.23 |
| 52 Week High | $1.91 | $1.39 |
Technical Indicators
Market Signals| Indicator | COCH | MLSS |
|---|---|---|
| Relative Strength Index (RSI) | 36.77 | 32.97 |
| Support Level | $0.67 | $0.23 |
| Resistance Level | $0.75 | $0.31 |
| Average True Range (ATR) | 0.06 | 0.04 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 0.53 | 21.54 |
Price Performance
Historical ComparisonAbout COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.
About MLSS Milestone Scientific Inc.
Milestone Scientific Inc is a biomedical technology company. The company is engaged in pioneering proprietary, technological systems and solutions for the medical and dental markets. The company develops, manufactures, markets, and sells the computer-controlled system for the improved and painless delivery of local anesthetics. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. The Company conducts its business through two reportable segments: Dental and Medical.